Selective on-line extraction of trans-resveratrol and emodin from Polygonum cuspidatum using molecularly imprinted polymer

Journal of Chromatographic Science

Volumn 46, Issue 8, 2008, Pages 739-742

  Zhuang, Xiaolei ^a   Dong, Xiangchao ^a   Ma, Shujuan ^b   Zhang, Ti ^a  

^a NANKAI UNIVERSITY   (China)

^b SHANXI NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

POLYGONUM CUSPIDATUM;

EMODIN; POLYMER; RESVERATROL; STILBENE DERIVATIVE;

ARTICLE; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATION AND PURIFICATION; METHODOLOGY; POLYGONUM CUSPIDATUM;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EMODIN; POLYGONUM CUSPIDATUM; POLYMERS; STILBENES;

EID: 51849155187     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chromsci/46.8.739     Document Type: Article

References (23)

1. Jiangsu New Medical College. Encyclopedia of Traditional Chinese Medicine. Shanghai Science and Technology Press, Shanghai, 2001, pp. 1329.
2. D. Delmas, A. Lancon, D. Colin, B. Jannin, and N. Latruffe. Resveratrol as a chemopreventive agent: A promising molecule for fighting cancer. Curr. Drug Targets 7: 423-442 (2006).
3. B. Olas and B. Wachowicz. Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets 16: 251-260 (2005).
4. X.Y. Xu and L.M. Pan. Medical care function of resveratrol and polydatin in natural product. Li Shizhen Med. and Mater. Medica Res. 15: 93-95 (2004).
5. F. Wolter and J. Stein. Biological activities of resveratrol and its analogs. Drugs Future 27: 949-959 (2002).
6. H.L. Ratan, W.P. Steward, A.J. Gescher, and J.K. Mellon. Resveratrol - A prostate cancer chemopreventive agent? Urol. Oncol. 7: 223-227 (2002).
7. D.K. Das and N. Maulik. Resveratrol in cardioprotection: A therapeutic promise of alternative medicine. Mol. Interv. 6: 36-47 (2006).
8. G. Srinivas, R.J. Anto, P. Srinivas, S. Vidhyalakshmi, V.P. Senan, and D. Karunagaran. Emodin induces apoptosis of human cervical cancer cells through poly (ADP-ribose) polymerase cleavage and activation of caspase-9. Eur. J. Pharmacol. 473: 117-125 (2003).
9. Y.C. Chen, S.C. Shen, W.R. Lee, F.L. Hsu, H.Y. Lin, C.H. Ko, and S.W. Tseng. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production. Biochem. Pharmacol. 64: 1713-1724 (2002).
10. H.Z. Lee. Effects andmechanisms of emodin on cell death in human lung squamous cell carcinoma. Br. J. Pharmacol. 134: 11-20 (2001).
11. Y. Bai, J.L. Pan, and W.W. Su. Research development of resveratrol and polydatin. J. Chin. Med. Mater. 27: 55-59 (2004).
12. Technology of Extracting and Separating Active Components of Traditional Chinese Medicine. Y.H. Lu, Ed. Chemical Industry Press, Beijing, BJ, 2005, pp. 163-164.
13. L.I. Andersson. Molecular imprinting: developments and applications in the analytical chemistry field. J. Chromatogr. B. 745: 3-13 (2000).
14. J. Olsen, P. Martin, and I.D. Wilson. Molecular imprints as sorbents for solid phase extraction: potential and applications. Anal. Commun. 35: 13H-14H (1998).
15. V.T. Remcho and Z.J. Tan. MIPs as chromatographic stationary phases for molecular recognition. Anal. Chem. 71: 248A-255A (1999).
16. L. Schweitz, L.I. Andersson, and S. Nilsson. Molecular imprint-based stationary phases for capillary electrochromatography. J. Chromatogr. A 817: 5-13 (1998).
17. G. Vlatakis, L.I. Andersson, R. Müller, and K. Mosbach. Drug assay using antibody mimics made by molecular imprinting. Nature 361: 645-647 (1993).
18. F. Lanza and B. Sellergren. The application of molecular imprinting technology to solid phase extraction. Chromatographia 53: 599-611 (2001).
19. H. Li, Y.J. Liu, Z.H. Zhang, H.P. Liao, L.H. Nie, and S.Z. Yao. Separation and purification of chlorogenic acid by molecularly imprinted polymer monolithic stationary phase. J. Chromatogr. A 1098: 66-74 (2005).
20. S.J. Ma, X.L. Zhuang, H.B. Wang, H.M. Liu, J. Li, and X.C. Dong. Preparation and characterization of trans-resveratrol imprinted polymers. Anal. Lett. 40: 321-333 (2007).
21. X.Y. Zhang. Chemical components and pharmacology function and separation of Polygonum cuspidatum. Tianjin Pharm. 11: 13-14 (1999).
22. Y. Hua, J.Y. Zhou, W. Ni, and C.X. Chen. Chemical components research of Polygonum cuspidatum. Nat. Prod. Res. Dev. 13: 16-18 (2001).
23. K. Xiao, L.J. Xuan, Y.M. Xu, and D.L. Bai. Research of water-soluble components in Polygonum cuspidatum. Chin. Trad. Herb. Drugs 34: 496-498 (2003).